Murae Organisor Limited Rights Issue (Murae Organisor Rights Issue 2024) Detail

₹46.47 Crores | Listing at BSE | Mon, Dec 30, 2024 - Mon, Jan 13, 2025

Murae Organisor Limited Logo

Murae Organisor Limited Rights Issue comprises 23.24 Cr equity shares aggregating to ₹46.47 Cr, offered at an issue price of ₹2 per share with a face value of ₹2 per share.

The record date for determining eligible shareholder is Dec 19, 2024, with the Rights Issue being offered in the entitlement ratio of 1 : 3.

The term of payment is defined as following : Full amount of Rs. 2.00/- per equity share will be payable on application by eligible equity shareholders.

The Rights Entitlements are expected to be credited to eligible demat accounts on [.]

The Rights Issue opens on Dec 30, 2024, and closes on Jan 13, 2025, with renunciation of Rights Entitlements permitted up to Jan 8, 2025.

The deemed date of allotment is Jan 21, 2025, following which the equity shares are expected to be credited to demat accounts on Jan 24, 2025 and listed at the BSE on Jan 28, 2025.

Bigshare Services Pvt.Ltd. is the Registrar to the Issue.

Investors are advised to refer to the Murae Organisor Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.

Record Date

Thu, Dec 19, 2024

Entitlement Ratio

1 : 3

Open Date

Mon, Dec 30, 2024

Close Date

Mon, Jan 13, 2025

Rights Issue Details

Rights Issue Timetable

Murae Organisor Limited Financial Information (Restated)

Murae Organisor Limited's revenue decreased by -75% and profit after tax (PAT) dropped by -97% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 2023
Assets119.8628.58
Revenue4.0616.36
Profit After Tax0.051.98
Net Worth55.8518.71
Reserves and Surplus6.426.37
Amount in ₹ Crore

About Murae Organisor Limited

Incorporated in 2012, Murae Organisor Limited is engaged in the pharmaceutical business, including the marketing, trading, and distribution of a diverse range of pharmaceutical products, such as antibiotics, anti-malarial drugs, and anti-allergic medications.

The company is committed to making quality healthcare and consumer products affordable and accessible worldwide, including in Africa, Latin America, and Southeast Asia. This is achieved through WHO-approved manufacturing facilities in India and strong distribution capabilities.

The company offers a wide range of products across various segments, including antibiotics, anti-malarial, dermatology, neurological, steroids, gynecology, and injections.

The company tailors its product offerings based on market trends and customer needs.

Objects of the Issue:

The Company intends to utilize the proceeds as follows:

  1. Incremental Working Capital Requirements
  2. General Corporate Purpose

Rights Issue Review

[Dilip Davda] The company is engaged in the marketing, trading and distribution of pharma products. This is the 2nd RI from the company since April 2023. It has posted dismal financial performance for the reported periods so far. Post-RI, hike in equity to the level of Rs. 185.90 cr. may pose its servicing issue. There is no promoter holding in this company. Though this RI is at par value, there is no harm in skipping it. It’s a “High Risk/No Return” bet. Read detail review...

Rights Issue Subscription Status

Murae Organisor Rights Issue 2024 got oversubscribed by 1.4 times by the end of the bidding period with total bid quantity received by BSE of 32,50,30,057 shares. Check Day by Day Subscription Details (Live Status)

DateBSE Bid Quantity Subscription Times

Jan 13 2025 17:00:00

32,50,30,057

1.40x

Company Contact Information

Murae Organisor Limited
A-1311
Sun West Bank, Ashram Road
Ashram Road P.O, Ahmedabad, 380009
Ahmedabad, Gujarat, 380009

Rights Issue Registrar

Bigshare Services Pvt.Ltd.

  • 8657578989/8069219065/8069219060
  • rightsissue@bigshareonline.com
  • Visit Website

Rights Issue FAQs

The Murae Organisor Rights Issue 2024 opens on Mon, Dec 30, 2024, and closes on Mon, Jan 13, 2025.

Murae Organisor Rights Issue 2024 Schedule

Last Date for credit of Rights Entitlements
Last Date for renunciation of Rights EntitlementsWed, Jan 8, 2025
Issue Opening DateMon, Dec 30, 2024
Issue Closing DateMon, Jan 13, 2025
Date of Allotment (on or about)Tue, Jan 21, 2025
Date of Credit (on or about)Fri, Jan 24, 2025
Date of Listing (on or about)Tue, Jan 28, 2025
Murae Organisor Rights Issue 2024 price is set at ₹2 per share.
The eligible shareholders are being offered 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date (Thu, Dec 19, 2024).
The record date for the Murae Organisor Rights Issue 2024 is Thu, Dec 19, 2024.
The issue size of Murae Organisor Rights Issue 2024 is of 23,23,70,539 equity shares at ₹2 per share aggregating up to ₹46.47 Crores.
The Letter of Offer for Murae Organisor Rights Issue 2024 can be downloaded here.

You can apply for Murae Organisor Rights Issue 2024 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Murae Organisor Rights Issue 2024 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Murae Organisor Rights Issue 2024 is available on the list.
  4. Click the Apply button next to the Murae Organisor Rights Issue 2024.
  5. Fill and check your information.
  6. Submit the application.

Steps to apply for Murae Organisor Rights Issue 2024 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Murae Organisor Rights Issue 2024 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

Compare: